Chemed Corp. Hits New 52-Week High of USD 517.69

Chemed Corp. has reached a significant milestone by hitting a new 52-week high of USD 517.69 on July 28, 2026. This achievement highlights the stock's notable activity within the hospital industry, where Chemed Corp. operates as a small-cap company with a market capitalization of USD 12,841 million. Despite a one-year performance decline of 4.99%, Chemed Corp. continues to demonstrate strong financial metrics. The company boasts a price-to-earnings (P/E) ratio of 48.00, indicating its valuation relative to earnings. Additionally, Chemed Corp. has a return on equity of 27.10%, showcasing its efficiency in generating profits from shareholders' equity. The stock also features a modest dividend yield of 0.27% and a price-to-book ratio of 13.11. The recent high reflects the stock's resilience and performance in a competitive market, contrasting with its 52-week low of USD 365.51. As Chemed Corp. continues to navigate the healthcare landscape, this milestone underscores its position within the industry.